Point72 Asset Management
MRK icon

Point72 Asset Management’s Merck MRK Stock Holding History

Point72 Asset Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.8M Sell
164,300
-487,800
-75% -$56.3M 0.03% 810
2025
Q4 		$68.6M Buy
652,100
+209,900
+47% +$19.7M 0.08% 291
2025
Q3 		$37.1M Buy
442,200
+153,800
+53% +$12.7M 0.06% 334
2025
Q2 		$22.8M Buy
288,400
+92,600
+47% +$7.36M 0.04% 449
2025
Q1 		$17.6M Buy
195,800
+127,600
+187% +$11.9M 0.04% 485
2024
Q4 		$6.78M Buy
68,200
+13,800
+25% +$1.42M 0.01% 848
2024
Q3 		$6.18M Buy
54,400
+30,800
+131% +$3.66M 0.02% 816
2024
Q2 		$2.92M Sell
23,600
-1,800
-7% -$232K 0.01% 990
2024
Q1 		$3.35M Sell
25,400
-145,800
-85% -$18M 0.01% 1097
2023
Q4 		$18.7M Buy
171,200
+44,900
+36% +$4.66M 0.05% 451
2023
Q3 		$13M Buy
+126,300
New +$13.6M 0.04% 547
2023
Q2 		– Sell
-6,600
Closed -$702K – 2550
2023
Q1 		$702K Sell
6,600
-26,700
-80% -$2.88M ﹤0.01% 1168
2022
Q4 		$3.69M Buy
+33,300
New +$3.4M 0.01% 824
2022
Q2 		– Sell
-2,295,000
Closed -$188M – 1545
2022
Q1 		$188M Buy
+2,295,000
New +$181M 0.75% 14
2021
Q4 		– Sell
-900,000
Closed -$67.6M – 1223
2021
Q3 		$67.6M Hold
900,000
– – 0.3% 63
2021
Q2 		$70M Buy
900,000
+376,000
+72% +$28M 0.31% 69
2021
Q1 		$38.5M Buy
+524,000
New +$38.7M 0.18% 150
2018
Q2 		– Sell
-2,829,600
Closed -$147M – 1112
2018
Q1 		$147M Buy
2,829,600
+1,991,200
+238% +$108M 0.61% 27
2017
Q4 		$45M Sell
838,400
-733,600
-47% -$40.7M 0.19% 146
2017
Q3 		$96M Buy
1,572,000
+995,600
+173% +$60.4M 0.43% 48
2017
Q2 		$35.3M Buy
+576,400
New +$35.1M 0.2% 142

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management's MRK Position: Q1 2026 in Review

Point72 Asset Management reduced its Merck (MRK) stake by 31% in Q1 2026, selling an estimated $48.2M and leaving 921,077 shares worth $111M. The position accounts for 0.14% of the portfolio, ranked #151.

Point72 Asset Management first reported a position in MRK in Q2 2014 and has held it in 30 quarters since. The position peaked at $294M in Q1 2022. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Point72 Asset Management held 921,077 shares of Merck worth $111M as of Q1 2026.
  • Point72 Asset Management sold 417,372 Merck shares in Q1 2026, an estimated $48.2M.
  • Merck made up 0.14% of Point72 Asset Management's portfolio in Q1 2026, its #151 holding.
  • Point72 Asset Management first reported a position in Merck in Q2 2014 and has held it in 30 quarters since.
  • Point72 Asset Management's Merck position peaked at $294M in Q1 2022.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.